Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/2/2025

Management of Niacin-Induced Diarrhea

Treatment and Monitoring

  • The Centers for Disease Control and Prevention recommends replacing ongoing fluid losses with oral rehydration solutions to prevent dehydration in patients with acute diarrhea caused by niacin 1
  • The Centers for Disease Control and Prevention suggests administering 10 mL/kg of oral rehydration solution for each watery stool passed in patients with mild to moderate diarrhea 1
  • The American Heart Association recommends monitoring for signs of dehydration such as decreased urine output, dry mouth, and dizziness in patients taking niacin 1
  • The American Heart Association suggests assessing for other symptoms of niacin toxicity including flushing, pruritus, and elevated liver enzymes in patients taking niacin 2
  • The European Society for Clinical Nutrition and Metabolism recommends evaluating for possible pellagra (niacin deficiency) if diarrhea occurs in patients with risk factors such as malnutrition, alcoholism, or malabsorptive states 3

Dietary Recommendations

  • The Centers for Disease Control and Prevention recommends maintaining adequate hydration with clear fluids in patients with niacin-induced diarrhea 1
  • The European Society for Clinical Nutrition and Metabolism suggests consuming foods high in soluble fiber to help firm stools in patients with niacin-induced diarrhea 3
  • The Centers for Disease Control and Prevention recommends avoiding foods high in simple sugars and fats that may worsen diarrhea in patients with niacin-induced diarrhea 1
  • The Centers for Disease Control and Prevention suggests continuing normal dietary intake as tolerated to maintain nutritional status in patients with niacin-induced diarrhea 1

Discontinuation of Niacin

  • The American Heart Association recommends considering discontinuation of niacin if diarrhea is severe, persistent, or significantly impacts quality of life despite management strategies, and evaluating alternative lipid-lowering therapies with lower rates of gastrointestinal side effects 2